Theramex announces an agreement with Enzene Biosciences Limited to develop and commercialize tocilizumab, a biosimilar for the treatment of rheumatoid arthritis

Theramex, a leading global specialty pharmaceutical company committed to promoting women and their health, has signed an agreement with Enzene Biosciences Limited to develop, approve and commercialize a biosimilar of Roche's reference drug RoActemra